These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 15228759)

  • 21. Recent developments in imaging of multiple sclerosis.
    Poloni G; Minagar A; Haacke EM; Zivadinov R
    Neurologist; 2011 Jul; 17(4):185-204. PubMed ID: 21712664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
    Bagnato F; Ohayon JM; Ehrmantraut M; Chiu AW; Riva M; Ikonomidou VN
    Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central nervous system atrophy and clinical status in multiple sclerosis.
    Zivadinov R; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):27S-35S. PubMed ID: 15228757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
    Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
    Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R; Minagar A
    J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of MRS and fMRI in multiple sclerosis.
    Tartaglia MC; Arnold DL
    Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study.
    Levesque I; Sled JG; Narayanan S; Santos AC; Brass SD; Francis SJ; Arnold DL; Pike GB
    J Magn Reson Imaging; 2005 Feb; 21(2):103-10. PubMed ID: 15666408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI to monitor treatment efficacy in multiple sclerosis.
    Fazekas F; Soelberg-Sorensen P; Comi G; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():50S-55S. PubMed ID: 17425736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
    Matthews PM; De Stefano N; Narayanan S; Francis GS; Wolinsky JS; Antel JP; Arnold DL
    Semin Neurol; 1998; 18(3):327-36. PubMed ID: 9817537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is progressive multiple sclerosis a gray matter disease?
    Geurts JJ
    Ann Neurol; 2008 Sep; 64(3):230-2. PubMed ID: 18825672
    [No Abstract]   [Full Text] [Related]  

  • 34. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
    Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
    Rumzan R; Chen X; Li YM
    Chin Med J (Engl); 2012 Jul; 125(13):2361-4. PubMed ID: 22882862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
    Filippi M; Rocca MA
    Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
    [No Abstract]   [Full Text] [Related]  

  • 38. Spinal cord imaging in multiple sclerosis.
    Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
    J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND; Kraft E; Stüve O
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.